The first class Venous Reflux Disease Treatment Market report has been formulated with the best-practice models, comprehensive market analysis and research methodologies so that clients attain perfect market segmentation and insights. Market research studies conducted in this market report are very attentive for the businesses which help them with the better decision making and develop better strategies about production, marketing, sales and promotion. To produce an excellent Venous Reflux Disease Treatment market report in an outstanding manner, most up-to-date and advanced tools and techniques have been utilized so that client achieves maximum benefits. The expected CAGR of the global venous reflux disease treatment market tends to be around 7.50% in the mentioned forecast period. The market was valued at USD 6.72 billion in 2022, and it would grow up to USD 12 billion by 2030.

Request Sample of Venous Reflux Disease Treatment Market Report @

Recent Developments:

In March 2021, Medtronic launched an Investigation Device Exemption (IDE) study to regulate the effectiveness and safety of the Abre venous self-expanding stent system to be used in the treatment of deep venous diseases.


  • Increase in Geriatric Population

The geriatric population is expected to increase the patient population globally, which boots the global venous reflux disease treatment market in the forecast period. According to the WHO, the global elderly population is expected to reach around 2 billion by 2050, from 617 million in 2015. Varicose veins are more common among older adults and women. For instance, as per the article published in the Journal of American Heart Association, around 23% of U.S. adults are projected to have varicose veins. This boost the market growth.

  • Increasing Demand for Noninvasive Surgeries

Noninvasive options have mostly replaced surgery. The preference for noninvasive surgeries has increased in recent years. This factor is expected to drive the market during the forecast period. Noninvasive methods also include minimum hospital stays, therefore saving time and cost. Many surgeons are adopting sclerotherapy, endovenous laser treatment, and radiofrequency ablation over conventional surgical practices. Thus, this factor increases the market growth.


  • Growing Initiatives by Different Organizations

Numerous organizations, such as the British Association of Sclerotherapies (BAS), undertake initiatives annually to raise awareness and encourage the adoption of several treatments. An increasing number of product approvals is also contributing to the market growth. For instance, in November 2020, Vascular Barcelona Devices (V.B. Devices) received approval of the C.E. mark for Varixio Pod Air as Class 1 s medical device intended for automated preparation of foam for varicose veins sclerotherapy. Thus, several initiatives like these are leading to market growth.

  • The emergence of Several Product Launches

Product launches, mergers and acquisitions, and investments in R&D for portfolio expansion are some of the major key strategies undertaken by the foremost players to support their market position. For instance, in August 2019, Surekha Varicose Veins Mumbai launched India’s first-ever Cryo Laser and Cryo Sclerotherapy (CLaCS) to treat small varicose veins in the leg and spider veins. This technology consists of A.R. (Augmented Reality), Transdermal laser, and sclerotherapy.

Global Venous Reflux Disease Treatment Market Scope and Market Size


  • Stage-1
  • Stage-2
  • Stage-3


  • Medication
  • Home Remedies
  • Non-Surgical and Procedures

Route of Administration

  • Oral
  • Parenteral
  • Others


  • Hospitals
  • Homecare
  • Speciality Centres
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Browse in-depth TOC on “Venous Reflux Disease Treatment Market”: By Type, Applications, Industry Size, Share, Growth, Segments, Analysis and Forecast @

Key players operating in the global venous reflux disease treatment market include:

  • Teleflex, Inc. (U.S.)
  • Mylan N.V. (U.S.)
  • VVT Medical (Israel),
  • BTG International Inc (U.K.)
  • AngioDynamics (U.S)
  • Medtronic (U.S.)
  • Candela Corporation (U.S)
  • biolitec® A.G. (Germany),
  • Sciton (U.S.)
  • Stryker Corporation (U.S.)
  • Cardinal Health. (U.S.)
  • Boston Scientific Corporation (U.S.)
  • Cook (U..S)

Profound Questions Answered in this Report:

  • What was the size of the emerging Venous Reflux Disease Treatment market opportunities, market risk and market overview by value in 2023?
  • What factors are affecting the strength of competition in the emerging Venous Reflux Disease Treatment market?
  • How large is the emerging Venous Reflux Disease Treatment market in relation to its regional counterparts?
  • What are the developments in the global market and forecast of market size up to 2030?
  • What will be the share of the emerging Venous Reflux Disease Treatment market in 2030?
  • What is the Venous Reflux Disease Treatment Market size in different countries around the world?
  • Are the markets growing or decreasing and company profile including analysis of product portfolio, revenue, SWOT analysis and latest developments of the company?
  • How are the market opportunities and threats faced by the vendors in the Venous Reflux Disease Treatment industry?
  • How are different product groups developing?
  • Who are the distributors, traders and dealers of Venous Reflux Disease Treatment market?
  • How are the markets forecast to develop in the future?

Request for PDF Brochure of This Report@

Browse More Reports:

About Data Bridge Market Research, Private Ltd

Data Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.


Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475